Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Todd D. Wiener who wrote (374)	3/26/1999 8:35:00 AM
From: Fred Hazeltine	Respond to of 420

Todd Weiner is probably right that there are better values out there. However Novacare is a compeling buy.They are a market leader in prosthetics and highly respected in phy. rehab.Market leaders are important today There problems do not revert to any improper actions on there part, simply a drastic change in medicare reimbursment which has all but paralyzed the long term care industry. NOV has a plan on how to proceed from this point, I have listened to it on tape, and am betting it will work.They could end up with much greater market share , and should medicare relax these strict changes which began 1/1/99 they would benefit greatly.Medical sevice stocks are out of favor. Should this change it would be another plus. I have spent a lot of time on this company and feel I understand it. I see miniscule risk here and great rewards. My views, Fred